Primary |
Age-related Macular Degeneration |
81.2% |
Macular Degeneration |
11.1% |
Exudative Senile Macular Degeneration Of Retina |
1.8% |
Choroidal Neovascularisation |
1.5% |
Rectosigmoid Cancer |
0.9% |
Wet Macular Degeneration |
0.9% |
Central Retinal Vein Occlusion |
0.3% |
Erectile Dysfunction |
0.3% |
Exudative Senile Macular Degenerative Of Retina |
0.3% |
Hypertension |
0.3% |
Polypoidal Choroidal Vasculopathy |
0.3% |
Pre-existing Condition Improved |
0.3% |
Retinal Degeneration |
0.3% |
Retinal Vein Occlusion |
0.3% |
Wet Macular Degeneration |
0.3% |
|
Visual Acuity Reduced |
19.0% |
Death |
15.7% |
Vitritis |
7.8% |
Retinal Haemorrhage |
7.1% |
Vitreous Floaters |
7.1% |
Uveitis |
6.3% |
Endophthalmitis |
5.2% |
Cerebrovascular Accident |
3.0% |
Eye Inflammation |
3.0% |
Myocardial Infarction |
3.0% |
Vision Blurred |
3.0% |
Eye Haemorrhage |
2.6% |
Visual Impairment |
2.6% |
Anterior Chamber Inflammation |
2.2% |
Blindness |
2.2% |
Vitrectomy |
2.2% |
Vitreous Opacities |
2.2% |
Eye Pain |
1.9% |
Macular Oedema |
1.9% |
Non-infectious Endophthalmitis |
1.9% |
|
Secondary |
Age-related Macular Degeneration |
57.5% |
Product Used For Unknown Indication |
27.5% |
Diabetic Vascular Disorder |
5.0% |
Macular Degeneration |
5.0% |
Wet Macular Degeneration |
5.0% |
|
Visual Acuity Reduced |
25.8% |
Death |
16.1% |
Cerebrovascular Accident |
12.9% |
Macular Fibrosis |
6.5% |
Pseudoendophthalmitis |
6.5% |
Anterior Chamber Inflammation |
3.2% |
Corneal Disorder |
3.2% |
Deep Vein Thrombosis |
3.2% |
Endophthalmitis |
3.2% |
Haemorrhage |
3.2% |
Non-infectious Endophthalmitis |
3.2% |
Rash |
3.2% |
Retinal Detachment |
3.2% |
Transient Ischaemic Attack |
3.2% |
Vitreous Opacities |
3.2% |
|
Concomitant |
Age-related Macular Degeneration |
27.3% |
Eye Disorder |
13.6% |
Chronic Obstructive Pulmonary Disease |
9.1% |
Depression |
9.1% |
Macular Degeneration |
9.1% |
Chorioretinopathy |
4.5% |
Glaucoma |
4.5% |
Hypothyroidism |
4.5% |
Major Depression |
4.5% |
Open Angle Glaucoma |
4.5% |
Product Used For Unknown Indication |
4.5% |
Vitamin D Decreased |
4.5% |
|
Cerebrovascular Accident |
22.2% |
Anterior Chamber Cell |
11.1% |
Retinal Haemorrhage |
11.1% |
Transient Ischaemic Attack |
11.1% |
Underdose |
11.1% |
Vision Blurred |
11.1% |
Visual Acuity Reduced |
11.1% |
Weight Decreased |
11.1% |
|